Infusion & Vascular Access

Exploring Approaches 'Beyond the Bundle' to Help Decrease Vascular Access Device-Associated Infections

May 5, 2017

It has been more than 10 years since The New England Journal of Medicine published the Keystone project’s ground breaking work on reducing ICU CLABSIs using a central line insertion bundle. Since that time, this has become the absolute standard throughout healthcare settings in the United States. When it comes to completing the central line insertions checklist, many of us only accept “yes” and “yes with prompting” as possible responses. Our accrediting agencies expect this as a standard of practice.

Diligence Encouraged to Minimize PVAD Complications

April 5, 2017

Peripheral venous access devices (PVADs) are considered safer and easier to manage than central lines, but safer doesn’t mean without risk, and PVADs still require diligence to prevent complications, according to an article in Critical Ca

Product Evaluation & Purchasing: IV and Catheter-Related Technology

March 3, 2017

In this new series for 2017, we offer insights from experts in industry and in healthcare delivery regarding smart evaluation and purchasing of infection prevention and control-related products. In this installment, we address IV and catheter-related products.

Medical Glue Reduces IV Drip Failure, Infection

December 6, 2016

Australian researchers have found a new way to make one of the most common medical procedures in the world - placing drips or intravenous (IV) lines - safer, less painful and potentially more cost effective. The researchers, who were funded by the Emergency Medicine Foundation of Australia (EMF), found that using medical skin glue to hold hospital drips in place significantly reduced the need to replace them due to infection, pain, blockage or falling out.

Using Infusion Therapy Standards to Enhance Prevention of Device-Associated Bloodstream Infections

August 9, 2016

As infection preventionists (IPs), the Centers for Disease Control and Prevention (CDC)’s Guidelines for the Prevention of Intravascular Device Associated Infections have long served as the cornerstone of much of our policy development. When the SHEA/IDSA Compendium documents were released those too served as a source of guidance.  What sometimes has been overlooked have been the Infusion Nurses Society standards which were updated most recently earlier this year and currently reflect the latest evidence based recommendations for all aspects of infusion therapy across all disciplines involved. To keep moving the needle beyond the status quo we need to expand our involvement beyond just hand and skin antisepsis (an over simplification of our role!) and help with all aspects of vascular access and infusion therapy to impact the overall quality of care for these prevalent devices.

Pages